NCT03233724 2023-05-31Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal CarcinomasNational Institutes of Health Clinical Center (CC)Phase 1/2 Terminated9 enrolled 14 charts
NCT01479348 2020-06-02Imaging Study for FdCyd and THU Cancer TreatmentNational Institutes of Health Clinical Center (CC)Phase EARLY_PHASE1 Terminated5 enrolled 12 charts